Issues related to overadherence to oral chemotherapy or targeted agents

Clinical Journal of Oncology Nursing

Volumn 17, Issue 6, 2013, Pages 604-609

  Spoelstra, Sandra L ^a   Given, Barbara A ^a   Given, Charles W ^b   Grant, Marcia ^c   Sikorskii, Alla ^d   You, Mei ^d   Decker, Veronica ^e  

^a College of Nursing ^*  (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e FLORIDA HOSPITAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; DEPRESSION; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASMS; NURSING; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PSYCHOLOGY;

ADMINISTRATION, ORAL; AGED; ANTINEOPLASTIC AGENTS; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT COMPLIANCE;

EID: 84893090480     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/13.CJON.17-06AP     Document Type: Article

References (16)

1. Blasdel, C., & Bubalo, J. (2006). Adherence to oral cancer therapies: Meeting the challenge of new patient care needs. Retrieved from http://www.clinicaloncology.com/download/563SR-Novartis.pdf
2. Borner, M.M., Dietrich, D.R., Morant, R., Honegger, H., Wernli, M.,... Roth, A.D. (2002). Phase II study of capecitabine and oxaliplatin in first-and second-line treatment of advance or metastatic colorectal cancer. Journal of Clinical Oncology, 20, 1759-1766.
3. Claxton, A.J., Cramer, J., & Pierce, C. (2001). A systematic review of the associations between dose regimens and medication compliance. Clinical Therapeutics, 23, 1296-1310. doi:10.1016/S0149-2918 (01)80109-0
4. Escalada, P., & Griffiths, P. (2006). Do people with cancer comply with oral chemotherapy treatments? British Journal of Community Nursing, 11, 532-536.
5. Findlay, M., von Minckwitz, G., & Wardley, A. (2008). Effective oral chemotherapy for breast cancer: Pillars of strength. Annals of Oncology, 19, 212-222. doi:10.1093/annonc/mdm285
6. Given, B., Given, C.W., McCorkle, R., Kozachik, S., Cimprich, B., Rahbar, M.H., & Wojcik, C. (2002). Pain and fatigue management: Results of a nursing randomized clinical trial. Oncology Nursing Forum, 29, 949-956. doi:10.1188/02.ONF.949-956
7. Given, C.W., Given, B., Azzouz, F., Kozachik, S., & Stommel, M. (2001). Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients. Journal of Pain and Symptom Management, 21, 456-466. doi:10.1016/S0885-3924 (1001)00284-00286.
8. Given, C.W., Stommel, M., Given, B., Osuch, J., Kurtz, M.E., & Kurtz, J.C. (1993). The influence of cancer patients' symptoms and functional states on patients' depression and family caregivers' reaction and depression. Health Psychology, 12, 277-285. doi:10.1037/0278-6133.12.4.277
9. Leventhal, H., Nerenz, D.R., Leventhal, E.A., Love, R.R., & Bendena, L.M. (1991). The behavioral dynamics of clinical trials. Preventive Medicine, 20, 132-146. doi:10.1016/0091-7435(91)90014-U
10. Mayer, E.L., Partridge, A.H., Harris, L.N., Gelman, R.S., Schumer, S.T., Burstein, H.J., & Winer, E.P. (2009). Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer. Breast Cancer Research and Treatment, 117, 615-623.
11. Radloff, L.S. (1977). The CES-D scale: A self report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
12. Sharma, S., & Saltz, L. (2000). Oral chemotheraputic agents for colorectal cancer. Oncologist, 5, 99-107. doi:10.1634/theoncologist.5-2-99
13. Spoelstra, S., Given, B.A., Given, C.W., Grant, M., Sikorskii, A., You, M., & Decker, V. (2013). An intervention to improve adherence and management of symptoms for patients prescribed oral chemotherapy agents: An exploratory study. Cancer Nursing, 36, 18-28. doi:10.1097/NCC.0b013e3182551587
14. Spoelstra, S., & Given, C.W. (2011). Assessment and measurement of adherence to oral antineoplastic agents. Seminars in Oncology Nursing, 27, 116-132. doi:10.1016/j.soncn.2011.02.004
15. Urquart, J., & Vrijens, B. (2005). New findings about patient adherence to prescribed drug dosing regimens. European Journal of Hospital Pharmacy Science, 11(5), 103-106.
16. Vrijens, R., Gross, R., Goetghebeur, E., De Klerk, E., & Urquhart, J. (2002). Dose timing information improves the clinical exploratory power of data on patient compliance with antiretroviral drug regimens. In M. Danhof, M. Karlsson, & R.J. Powell (Eds.), Measurement and kinetics of in vivo drug effects: Advances in simultaneous pharmacokinetic/pharmacodynamic modeling-Part 2: Contributed papers (pp. 86-88). Leiden, Amsterdam: Center for Drug Research.